Dry eyes rarely come up in conversations about perimenopause the way hot flashes or sleep problems do, but the connection is genuinely well documented, and some of the research contains a real surprise: the relationship between hormones and dry eyes is more complicated than “more estrogen equals better tear production.”
Here is what the research actually shows about hormones and your eyes, including a finding that runs counter to what you might expect.
Key Takeaways
- Dry eye disease is significantly more common in perimenopausal and postmenopausal women, and sex hormone receptors are directly present in the glands that produce your tears.
- Counterintuitively, research has found that estrogen-containing hormone therapy is associated with an increased, not decreased, risk of dry eye syndrome.
- Declining androgens, not just estrogen, appear to play a significant and sometimes underappreciated role in this specific symptom.
How Common Is This, Really
Genuinely common. One clinical review cites that dry eyes affect roughly 61% of perimenopausal and menopausal women, a substantial majority. A separate review published in the Journal of Mid-Life Health confirms that dry eye disease is more prevalent in women generally and specifically concentrated in the menopausal and postmenopausal age group, a pattern believed to stem directly from shifting sex hormone balance.
Why Hormones Affect Your Eyes at All
This connection is not incidental. Your tear film has three components: an aqueous layer from the lacrimal gland, a lipid layer from the meibomian glands in your eyelids, and mucin from cells in the conjunctiva. Research reviewing this system confirms that sex steroid receptors are present directly on the meibomian glands, which are the sebaceous glands responsible for producing the oily component of your tears. Both estrogen and androgen receptors have been identified in the lacrimal gland as well, meaning these hormones have a direct, structural line of influence over your eyes, not an indirect or coincidental one.
The Surprising Finding: Estrogen Therapy and Dry Eye Risk
Here is where the research gets genuinely counterintuitive. A large cohort study within the Women’s Health Study, following more than 25,000 postmenopausal women, found that women using hormone replacement therapy had a meaningfully higher risk of dry eye syndrome than women not using it, with estrogen used alone associated with a stronger increase in risk than combined estrogen-progesterone therapy. The study also found that each additional three years of hormone therapy use was associated with a further 15% increase in dry eye risk.
This runs against the intuitive assumption that replacing declining estrogen should straightforwardly improve a hormone-related symptom. A more recent review reinforces this pattern, noting that postmenopausal hormone therapy with estrogen, or estrogen plus progestogen, has shown limited benefit for dry eye symptoms and may even worsen meibomian gland function and reduce tear film stability in some research. This is exactly the kind of counterintuitive, honestly reported finding worth taking seriously rather than smoothing over to fit a simpler narrative.
Androgens May Be the More Important Piece
While estrogen’s role turns out to be complicated, androgens appear more consistently important for healthy tear production. Research reviewing sex hormones and the ocular surface notes that androgen levels are essential for normal lacrimal gland function and structure, and separate research has found systemic treatment combining estrogen with the androgen methyltestosterone showed more promise for treating dry eye than estrogen alone. Since androgen levels also decline with age in women, though on a different timeline than the sharper estrogen and progesterone drop at menopause, this may help explain why dry eye becomes so much more common during this window even though the estrogen-alone data looks paradoxical.
| Hormone | Role in Tear Film | Research Finding |
|---|---|---|
| Estrogen (as HRT) | Complex, not straightforwardly protective | Associated with increased dry eye risk in large cohort study |
| Androgens | Support lacrimal gland structure and function | Decline may be a more direct driver of dry eye |
| Progesterone (with estrogen) | Somewhat lower risk increase than estrogen alone | Still associated with increased risk versus no HRT |
What This Means Practically
If you are experiencing new or worsening dry eye around perimenopause, this is a genuine, hormonally connected symptom worth mentioning to both your gynecologist and an eye doctor, rather than assuming it is unrelated or purely a result of screen use or aging alone. If you are already on hormone therapy for other menopausal symptoms and have noticed new dry eye, this is a real, documented association worth discussing with your doctor rather than dismissing as coincidental. Standard dry eye treatments, including artificial tears and other ophthalmologist-guided options, remain appropriate regardless of the underlying hormonal contribution.
Frequently Asked Questions
Does Starting Hormone Therapy Make Dry Eyes Worse?
Research, including a large cohort study, has found hormone therapy, particularly estrogen used alone, associated with an increased risk of dry eye syndrome rather than a protective effect. This is worth discussing with your doctor if you notice new dry eye symptoms after starting hormone therapy.
Why Do My Eyes Feel Drier Since Perimenopause Started?
Sex hormone receptors are present directly on the glands responsible for tear production, including the meibomian and lacrimal glands, so hormonal shifts during this transition have a direct, structural pathway to affecting your tear film, independent of screen use or other lifestyle factors.
Is There a Hormonal Treatment Specifically for Dry Eyes?
Research on androgen-containing treatments has shown some promise, but this is a decision to make with an eye doctor given how complex and sometimes counterintuitive the hormone research in this area has proven to be, rather than something to pursue based on general assumptions about hormones and dryness.
Selected Sources
- Dry Eye Syndrome in Menopause and Perimenopausal Age Group (Journal of Mid-Life Health)
- Hormone Replacement Therapy and Dry Eye Syndrome (PubMed, Women’s Health Study)
- Tear Film Steroid Profiling in Dry Eye Disease (PMC)
This article is for general educational purposes and is not a substitute for personalized medical advice. Talk with an eye care provider and your gynecologist about persistent or new dry eye symptoms during perimenopause or while on hormone therapy.